1. 2022-RA-1276-ESGO Pembrolizumab monotherapy for advanced clear cell gynaecological cancer: phase II PEACOCC trial. (20th October 2022) Authors: Miller, Rowan E; Clamp, Andrew; Gourley, Charlie; Roux, Rene; Hall, Marcia; Devlin, Michael-John; Nirsimloo, Rachel; Kounnis, Valentinos; Hughes, Laura; Counsell, Nicholas; Farrelly, Laura; Kristeleit, Rebecca S Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Genomic testing in high-grade serous ovarian cancer: current options and future development. Issue 3 (6th March 2023) Authors: Devlin, Michael-John; Miller, Rowan Journal: International journal of gynecological cancer Issue: Volume 33:Issue 3(2023) Page Start: 358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗